These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 15747065)
1. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex. Hämmerlein A; Weiske J; Huber O Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065 [TBL] [Abstract][Full Text] [Related]
2. Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling. Ishitani T; Ninomiya-Tsuji J; Matsumoto K Mol Cell Biol; 2003 Feb; 23(4):1379-89. PubMed ID: 12556497 [TBL] [Abstract][Full Text] [Related]
3. Signaling through beta-catenin and Lef/Tcf. Novak A; Dedhar S Cell Mol Life Sci; 1999 Oct; 56(5-6):523-37. PubMed ID: 11212302 [TBL] [Abstract][Full Text] [Related]
4. The ubiquitin-proteasome pathway and serine kinase activity modulate adenomatous polyposis coli protein-mediated regulation of beta-catenin-lymphocyte enhancer-binding factor signaling. Easwaran V; Song V; Polakis P; Byers S J Biol Chem; 1999 Jun; 274(23):16641-5. PubMed ID: 10347231 [TBL] [Abstract][Full Text] [Related]
5. CK2 phosphorylation of the armadillo repeat region of beta-catenin potentiates Wnt signaling. Song DH; Dominguez I; Mizuno J; Kaut M; Mohr SC; Seldin DC J Biol Chem; 2003 Jun; 278(26):24018-25. PubMed ID: 12700239 [TBL] [Abstract][Full Text] [Related]
6. Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation. Yuan H; Mao J; Li L; Wu D J Biol Chem; 1999 Oct; 274(43):30419-23. PubMed ID: 10521419 [TBL] [Abstract][Full Text] [Related]
8. Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein. Naishiro Y; Yamada T; Idogawa M; Honda K; Takada M; Kondo T; Imai K; Hirohashi S Oncogene; 2005 Apr; 24(19):3141-53. PubMed ID: 15735679 [TBL] [Abstract][Full Text] [Related]
9. Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1. Aoki M; Hecht A; Kruse U; Kemler R; Vogt PK Proc Natl Acad Sci U S A; 1999 Jan; 96(1):139-44. PubMed ID: 9874785 [TBL] [Abstract][Full Text] [Related]
10. Lymphoid enhancer factor-1 blocks adenomatous polyposis coli-mediated nuclear export and degradation of beta-catenin. Regulation by histone deacetylase 1. Henderson BR; Galea M; Schuechner S; Leung L J Biol Chem; 2002 Jul; 277(27):24258-64. PubMed ID: 11986304 [TBL] [Abstract][Full Text] [Related]
11. The human Frizzled 6 (HFz6) acts as a negative regulator of the canonical Wnt. beta-catenin signaling cascade. Golan T; Yaniv A; Bafico A; Liu G; Gazit A J Biol Chem; 2004 Apr; 279(15):14879-88. PubMed ID: 14747478 [TBL] [Abstract][Full Text] [Related]
12. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription. Sakanaka C; Weiss JB; Williams LT Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3020-3. PubMed ID: 9501208 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation. Ha NC; Tonozuka T; Stamos JL; Choi HJ; Weis WI Mol Cell; 2004 Aug; 15(4):511-21. PubMed ID: 15327768 [TBL] [Abstract][Full Text] [Related]
14. Beta-catenin can act as a nuclear import receptor for its partner transcription factor, lymphocyte enhancer factor-1 (lef-1). Asally M; Yoneda Y Exp Cell Res; 2005 Aug; 308(2):357-63. PubMed ID: 15936755 [TBL] [Abstract][Full Text] [Related]
15. Biochemical and structural characterization of β-catenin interactions with nonphosphorylated and CK2-phosphorylated Lef-1. Sun J; Weis WI J Mol Biol; 2011 Jan; 405(2):519-30. PubMed ID: 21075118 [TBL] [Abstract][Full Text] [Related]
16. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells. Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231 [TBL] [Abstract][Full Text] [Related]
17. Wnt/beta-catenin signaling activates growth-control genes during overload-induced skeletal muscle hypertrophy. Armstrong DD; Esser KA Am J Physiol Cell Physiol; 2005 Oct; 289(4):C853-9. PubMed ID: 15888552 [TBL] [Abstract][Full Text] [Related]
18. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells. Maupas-Schwalm F; Robinet C; Augé N; Thiers JC; Garcia V; Cambus JP; Salvayre R; Nègre-Salvayre A Cancer Res; 2005 Jan; 65(2):526-32. PubMed ID: 15695395 [TBL] [Abstract][Full Text] [Related]
19. Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro. Tutter AV; Fryer CJ; Jones KA Genes Dev; 2001 Dec; 15(24):3342-54. PubMed ID: 11751639 [TBL] [Abstract][Full Text] [Related]
20. Wnt-signalling pathway in ovarian epithelial tumours: increased expression of beta-catenin and GSK3beta. Rask K; Nilsson A; Brännström M; Carlsson P; Hellberg P; Janson PO; Hedin L; Sundfeldt K Br J Cancer; 2003 Oct; 89(7):1298-304. PubMed ID: 14520463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]